Biomarker approaches in major depressive disorder evaluated in the context of current hypotheses.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Biomarkers in Medicine

• Publication date

  2015-03-03

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.2217/bmm.14.114PMID 25731213
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• C9ORF72 and the FTD-ALS spectrum: A systematic review of neuroimaging studies

  2015cited by this paper
• Part 1 Chapter 2 Emotional valence modulates brain functional abnormalities in depression : evidence from a meta-analysis of fMRI studies

  2015cited by this paper
• Interaction between stress and the BDNF Val66Met polymorphism in depression: a systematic review and meta-analysis

  2014cited by this paper
• The Genetics of MDD – A Review of Challenges and Opportunities

  2014cited by this paper
• Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N=9484)

  2014cited by this paper
• Inflammatory and Metabolic Dysregulation and the 2-Year Course of Depressive Disorders in Antidepressant Users

  2014cited by this paper
• Altered systemic cortisol metabolism in bipolar disorder and schizophrenia spectrum disorders.

  2014cited by this paper
• Microglia as modulators of cognition and neuropsychiatric disorders

  2013cited by this paper
• Decreased serum levels of the angiogenic factors VEGF and TGF-β1 in Alzheimer's disease and amnestic mild cognitive impairment.

  2013cited by this paper
• Do Cytokines Really Sing the Blues?

  2013cited by this paper
• The association between immune activation and manic symptoms in patients with a depressive disorder

  2013cited by this paper
• Proteomics reveals energy and glutathione metabolic dysregulation in the prefrontal cortex of a rat model of depression.

  2013cited by this paper
• Neurogenesis, inflammation and behavior.

  2013cited by this paper
• Depression pathogenesis and treatment: what can we learn from blood mRNA expression?

  2013cited by this paper
• Serum Brain-Derived Neurotrophic Factor Levels in Different Neurological Diseases

  2013cited by this paper
• Evidence for a differential role of HPA-axis function, inflammation and metabolic syndrome in melancholic versus atypical depression

  2013cited by this paper
• Neuroreceptor imaging in depression.

  2013cited by this paper
• Is Altered BDNF Biosynthesis a General Feature in Patients with Cognitive Dysfunctions?

  2013cited by this paper
• A new animal model of (chronic) depression induced by repeated and intermittent lipopolysaccharide administration for 4 months.

  2013cited by this paper
• Neural correlates of dysfunctional emotion regulation in major depressive disorder. A systematic review of neuroimaging studies.

  2013cited by this paper
• 5‐HT radioligands for human brain imaging with PET and SPECT

  2013cited by this paper
• Hippocampal synaptic dysregulation of exo/endocytosis-associated proteins induced in a chronic mild-stressed rat model.

  2013cited by this paper
• EEG biomarkers in major depressive disorder: Discriminative power and prediction of treatment response

  2013cited by this paper
• Emotional valence modulates brain functional abnormalities in depression: evidence from a meta-analysis of fMRI studies.

  2013cited by this paper
• Differential association of somatic and cognitive symptoms of depression and anxiety with inflammation: findings from the Netherlands Study of Depression and Anxiety (NESDA).

  2013cited by this paper
• Age-associated decrease in serum glial cell line-derived neurotrophic factor levels in patients with major depressive disorder.

  2013cited by this paper
• Peripheral vascular endothelial growth factor level is associated with antidepressant treatment response: results of a preliminary study.

  2013cited by this paper
• Steroid hormones and BDNF.

  2013cited by this paper
• Principle component analysis combined with matrix-assisted laser desorption ionization mass spectrometry for rapid diagnosing the sera of patients with major depression.

  2013cited by this paper
• Whole-exome sequencing identifies a polymorphism in the BMP5 gene associated with SSRI treatment response in major depression

  2013cited by this paper
• Neurochemical imaging and depressive behaviours.

  2013cited by this paper
• [Correlation of neurochemical metabolism with memory function in young adult patients with first-episode depression studied with proton magnetic resonance spectroscopy].

  2013cited by this paper
• Neutrophil gelatinase-associated lipocalin: a novel inflammatory marker associated with late-life depression.

  2013cited by this paper
• Diagnostic accuracy of serum brain derived neurotrophic factor concentration in antidepressant naïve patients with first major depression episode.

  2013cited by this paper
• Assessment of a multi-assay, serum-based biological diagnostic test for major depressive disorder: a Pilot and Replication Study

  2013cited by this paper
• Comparative proteomic analysis of plasma from major depressive patients: identification of proteins associated with lipid metabolism and immunoregulation.

  2012cited by this paper
• Neuroimaging Markers of Cellular Function in Major Depressive Disorder: Implications for Therapeutics, Personalized Medicine, and Prevention

  2012cited by this paper
• Phosphoproteomic differences in major depressive disorder postmortem brains indicate effects on synaptic function

  2012cited by this paper
• The Default Mode Network and Recurrent Depression: A Neurobiological Model of Cognitive Risk Factors

  2012cited by this paper
• Serotonin-1A receptor binding is positively associated with gray matter volume - A multimodal neuroimaging study combining PET and structural MRI

  2012cited by this paper
• Factors underlying variable DNA methylation in a human community cohort

  2012cited by this paper
• Identification of proteomic signatures associated with depression and psychotic depression in post-mortem brains from major depression patients

  2012cited by this paper
• Identification of blood-based molecular signatures for prediction of response and relapse in schizophrenia patients

  2012cited by this paper
• Association of depressive disorders, depression characteristics and antidepressant medication with inflammation

  2012cited by this paper
• The current state of play on the molecular genetics of depression

  2012cited by this paper
• Data-driven subtypes of major depressive disorder: a systematic review

  2012cited by this paper
• How does the social environment 'get into the mind'? Epigenetics at the intersection of social and psychiatric epidemiology.

  2012cited by this paper
• Major depressive disorder: new clinical, neurobiological, and treatment perspectives.

  2012cited by this paper
• Identification and Validation of Urinary Metabolite Biomarkers for Major Depressive Disorder*

  2012cited by this paper
• Amygdala activity and prefrontal cortex–amygdala effective connectivity to emerging emotional faces distinguish remitted and depressed mood states in bipolar disorder

  2012cited by this paper
• Plasma biomarkers of depressive symptoms in older adults

  2012cited by this paper
• Imaging treatment effects in depression

  2012cited by this paper
• Increased plasma VEGF levels in major depressive or manic episodes in patients with mood disorders.

  2012cited by this paper
• Serotonin-1A receptors in major depression quantified using PET: Controversies, confounds, and recommendations

  2012cited by this paper
• Regulation of cytoskeleton machinery, neurogenesis and energy metabolism pathways in a rat gene-environment model of depression revealed by proteomic analysis.

  2011cited by this paper
• Cross-national epidemiology of DSM-IV major depressive episode

  2011cited by this paper
• Vascular Endothelial Growth Factor (VEGF) serum concentration during electroconvulsive therapy (ECT) in treatment resistant depressed patients

  2011cited by this paper
• A short review on the psychoneuroimmunology of posttraumatic stress disorder: from risk factors to medical comorbidities.

  2011cited by this paper
• Poor replication of candidate genes for major depressive disorder using genome-wide association data

  2011cited by this paper
• Cytokines mediated inflammation and decreased neurogenesis in animal models of depression.

  2011cited by this paper
• Frontocingulate Dysfunction in Depression: Toward Biomarkers of Treatment Response

  2011cited by this paper
• Discovering imaging endophenotypes for major depression

  2011cited by this paper
• Beyond the serotonin hypothesis: mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders.

  2011cited by this paper
• Biomarkers in the Age of Omics: Time for a Systems Biology Approach

  2011cited by this paper
• Animal models of depression and anxiety: What do they tell us about human condition?

  2011cited by this paper
• Animal models of depression: molecular perspectives.

  2011cited by this paper
• The hippocampus in major depression: evidence for the convergence of the bench and bedside in psychiatric research?

  2011cited by this paper
• The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression.

  2011cited by this paper
• Depression and Hypothalamic-Pituitary-Adrenal Activation: A Quantitative Summary of Four Decades of Research

  2011cited by this paper
• Machine learning classification with confidence: Application of transductive conformal predictors to MRI-based diagnostic and prognostic markers in depression

  2011cited by this paper
• Glucocorticoids, cytokines and brain abnormalities in depression.

  2011cited by this paper
• In Vivo Monitoring of Adult Neurogenesis in Health and Disease

  2011cited by this paper
• Serum and plasma BDNF levels in major depression: A replication study and meta-analyses

  2010cited by this paper
• Integrating neurobiological markers of depression.

  2010cited by this paper
• Distribution volume ratio of serotonin and dopamine transporters in euthymic patients with a history of major depression - a dual-isotope SPECT study.

  2010cited by this paper
• Elevated amygdala activity to sad facial expressions: a state marker of bipolar but not unipolar depression.

  2010cited by this paper
• The Kraepelinian dichotomy – going, going... but still not gone

  2010cited by this paper
• Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity

  2010cited by this paper
• Modelling the molecular mechanisms of synaptic plasticity using systems biology approaches

  2010cited by this paper
• [11C]-PK11195 PET: quantification of neuroinflammation and a monitor of anti-inflammatory treatment in Parkinson's disease?

  2010cited by this paper
• Genetic variation in HTR2A influences serotonin transporter binding potential as measured using PET and [11C]DASB.

  2010cited by this paper
• Plasma levels of vascular endothelial growth factor and fibroblast growth factor 2 in patients with major depressive disorders

  2010cited by this paper
• Gene Expression Studies in Major Depression

  2010cited by this paper
• Investigating serotonergic function using positron emission tomography: overview and recent findings.

  2010cited by this paper
• In vivo imaging of neuroinflammation: a comparative study between [18F]PBR111, [11C]CLINME and [11C]PK11195 in an acute rodent model

  2010cited by this paper
• Altered expression of lipid metabolism and immune response genes in the frontal cortex of suicide completers.

  2010cited by this paper
• Stimulated gene expression profiles as a blood marker of major depressive disorder.

  2010cited by this paper
• Meta-analysis of the association between the monoamine oxidase-A gene and mood disorders

  2010cited by this paper
• Epigenetics and depression: current challenges and new therapeutic options

  2010cited by this paper
• Plasma Protein Biomarkers for Depression and Schizophrenia by Multi Analyte Profiling of Case-Control Collections

  2010cited by this paper
• [11C]-DPA-713 and [18F]-DPA-714 as New PET Tracers for TSPO: A Comparison with [11C]-(R)-PK11195 in a Rat Model of Herpes Encephalitis

  2009cited by this paper
• Brain monoamine oxidase A binding in major depressive disorder: relationship to selective serotonin reuptake inhibitor treatment, recovery, and recurrence.

  2009cited by this paper
• Glial cell-line derived neurotrophic factor (GDNF) concentrations in cerebrospinal fluid and serum of patients with early Alzheimer's disease and normal controls.

  2009cited by this paper
• Angiogenic factors in patients with current major depressive disorder comorbid with borderline personality disorder.

  2009cited by this paper
• Serotonin transporter binding with [123I]β-CIT SPECT in major depressive disorder versus controls: effect of season and gender

  2009cited by this paper
• Global Brain Gene Expression Analysis Links Glutamatergic and GABAergic Alterations to Suicide and Major Depression

  2009cited by this paper
• Cytokine, sickness behavior, and depression.

  2009cited by this paper
• Acid hydrolysis followed by matrix-assisted laser desorption/ionization mass spectrometry for the rapid diagnosis of serum protein biomarkers in patients with major depression.

  2009cited by this paper
• Neurobiological mechanisms in major depressive disorder

  2009cited by this paper
• Molecular tools for assessing human depression by positron emission tomography.

  2009cited by this paper

• PRE-CLINICAL NEUROPHARMACOLOGY EFFICACY AND TOXICITY OF AVENIA SATIVAUM IN RATS

  2026cites this paper
• The Administration of Melatonin Improved Depressive Behavior in Both Maximal Electroshock Seizure-Prone and Non-Seizure Mice After Undergoing Levetiracetam Treatment

  2025cites this paper
• Neurobiological mechanisms of antidepressant properties of psilocybin: A systematic review of blood biomarkers.

  2025cites this paper
• Gene–environment–brain topology reveals clinical subtypes of depression in UK Biobank

  2025cites this paper
• Advances and Challenges in Depression Marker Research

  2025cites this paper
• The Role of Mitochondrial Dysfunction-Mediated Changes in Immune Cytokine Expression in the Pathophysiology and Treatment of Major Depressive Disorder

  2025cites this paper
• Topological data analysis communities reveal gene-environment-brain subtypes of major depression in UK Biobank and multi-site cohorts

  2025cites this paper
• A longitudinal study of the mediator role of physical activity in the bidirectional relationships of cognitive function and specific dimensions of depressive symptoms.

  2024cites this paper
• Tissue-specific gene expression of genome-wide significant loci associated with major depressive disorder subtypes.

  2024cites this paper
• Assessment of biomarker stability and assay performance parameters for medical diagnosis: a case study of diagnosis of major depressive disorder.

  2024cites this paper
• Polyunsaturated fatty acids changes during electroconvulsive therapy in major depressive disorder.

  2023cites this paper
• Evaluation of a Nondepleted Plasma Multiprotein-Based Model for Discriminating Psychiatric Disorders Using Multiple Reaction Monitoring-Mass Spectrometry: Proof-of-Concept Study.

  2023cites this paper
• Effects of Anxious Depression on Antidepressant Treatment Response

  2023cites this paper
• Altered IL-3 and lipocalin-2 levels are associated with the pathophysiology of major depressive disorder: a case-control study

  2023cites this paper
• Artificial Intelligence-Based Major Depressive Disorder (MDD) Diagnosis Using Raman Spectroscopic Features of Plasma Exosomes.

  2023cites this paper
• Neuropsychological Effects of Antidepressants: Translational Studies.

  2023cites this paper
• Is depression the missing link between inflammatory mediators and cancer?

  2022cites this paper
• A game changer for bipolar disorder diagnosis using RNA editing-based biomarkers

  2022cites this paper
• DNA Methylation of POMC and NR3C1-1F and Its Implication in Major Depressive Disorder and Electroconvulsive Therapy

  2022cites this paper
• Excess body weight and specific types of depressive symptoms: Is there a mediating role of systemic low-grade inflammation?

  2022cites this paper
• Combined serum IL-6, C-reactive protein, and cortisol may distinguish patients with anhedonia in major depressive disorder

  2022cites this paper
• Binary disease prediction using tail quantiles of the distribution of continuous biomarkers

  2021cites this paper
• The associations of CNR1 SNPs and haplotypes with vulnerability and treatment response phenotypes in Han Chinese with major depressive disorder

  2021cites this paper
• Assessing Biomarker Stability and Assay Performance Parameters for the Use of Biomarkers in Mental Disorders; A Study of Early Stage Biomarker Assay Method Development

  2021influential citation
• Label-Free Liquid Chromatography–Mass Spectrometry Proteomic Analysis of the Urinary Proteome for Measuring the Escitalopram Treatment Response From Major Depressive Disorder

  2021cites this paper
• Discriminative Power of EEG-Based Biomarkers in Major Depressive Disorder: A Systematic Review

  2021cites this paper
• The associations of CNR1 SNPs and haplotypes with vulnerability and treatment response phenotypes in Han Chinese with major depressive disorder: A case–control association study

  2021cites this paper
• Role of Brain Imaging in Drug Development for Psychiatry.

  2021cites this paper
• Melatonin and Depression: A Translational Perspective From Animal Models to Clinical Studies

  2021cites this paper
• A Comparison between Spectral Power of Electroencephalogram at Rest (Eyes Closed) and Evoked Related Potential among Depressed and Healthy Individuals

  2021cites this paper
• Gender Differences in Developing Biomarker-Based Major Depressive Disorder Diagnostics

  2020cites this paper
• Association Between BDNF Gene Variant Rs6265 and the Severity of Depression in Antidepressant Treatment-Free Depressed Patients

  2020cites this paper
• Weighted Gene Coexpression Network Analysis Identifies Specific Modules and Hub Genes Related to Major Depression

  2020cites this paper
• Affect fluctuations examined with ecological momentary assessment in patients with current or remitted depression and anxiety disorders

  2020cites this paper
• Toward a New Model of Understanding, Preventing, and Treating Adolescent Depression Focusing on Exhaustion and Stress

  2020cites this paper
• The Relationalist Turn in Understanding Mental Disorders: From Essentialism to Embracing Dynamic and Complex Relations

  2020cites this paper
• Novel candidate genes for ECT response prediction—a pilot study analyzing the DNA methylome of depressed patients receiving electroconvulsive therapy

  2020cites this paper
• Retinal structural changes in mood disorders: The optical coherence tomography to better understand physiopathology?

  2020cites this paper
• University of Groningen Association Between BDNF Gene Variant Rs6265 and the Severity of Depression in Antidepressant Treatment-Free Depressed Patients Losenkov,

  2020cites this paper
• Brain-derived neurotrophic factor (BDNF) and inflammatory markers: Perspectives for the management of depression.

  2020cites this paper
• Towards precision medicine: What are the stratification hypotheses to identify homogeneous inflammatory subgroups.

  2020cites this paper
• NDT_A_244452 703..713

  2020cites this paper
• Rapid-acting antidepressants: shared neuropharmacological mechanisms

  2019cites this paper
• Major depressive disorder is associated with changes in a cluster of serum and urine biomarkers.

  2019cites this paper
• Biological and Lifestyle Risk Factors for Depression in the General Population

  2019cites this paper
• Counselors' Neuroscience Conceptualizations of Depression

  2019cites this paper
• Entropy analysis of heart rate variability and its application to recognize major depressive disorder: A pilot study

  2019cites this paper
• Investigating the potential role of BDNF and PRL genotypes on antidepressant response in depression patients: A prospective inception cohort study in treatment-free patients.

  2019cites this paper
• N-acetylcysteine (NAC) as add-on to antidepressant medication in therapy refractory major depressive disorder patients with increased inflammatory activity: study protocol of a double- blind randomized placebo-controlled trial

  2019cites this paper
• Sociodemographic, behavioral, and health-related risk factors for depression among men and women in a southern Brazilian city

  2019cites this paper
• Proteomic Markers for Depression.

  2019cites this paper
• Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial

  2019cites this paper
• Persistent depressive symptoms, HPA-axis hyperactivity, and inflammation: the role of cognitive-affective and somatic symptoms

  2019cites this paper
• Translational Shifts in Preclinical Models of Depression: Implications for Biomarkers for Improved Treatments.

  2018cites this paper
• Cortical Excitability and Activation of TrkB Signaling During Rebound Slow Oscillations Are Critical for Rapid Antidepressant Responses

  2018cites this paper
• The evolutionary old forebrain as site of action to develop new psychotropic drugs

  2018cites this paper
• N-acetylcysteine as add-on to antidepressant medication in therapy refractory major depressive disorder patients with increased inflammatory activity: study protocol of a double-blind randomized placebo-controlled trial

  2018cites this paper
• Interleukin, tumor necrosis factor-α and C-reactive protein profiles in melancholic and non-melancholic depression: A systematic review.

  2018cites this paper
• Automatic detection of major depressive disorder using electrodermal activity

  2018cites this paper
• Elevated hippocampal choline level is associated with altered functional connectivity in females with major depressive disorder: A pilot study.

  2018cites this paper
• Psychopharmacology: From serendipitous discoveries to rationale design, but what next?

  2018cites this paper
• University of Groningen N-acetylcysteine as add-on to antidepressant medication in therapy refractory major depressive disorder patients with increased inflammatory activity

  2018cites this paper
• From Serotonin to Neuroplasticity: Evolvement of Theories for Major Depressive Disorder

  2017cites this paper
• UvA-DARE ( Digital Academic Repository ) Fatty acids in context Neurometabolic perspectives on depression vulnerability

  2017cites this paper
• Circuits Regulating Pleasure and Happiness in Bipolar Disorder

  2017influential citation
• Inherent vulnerabilities in monoaminergic pathways predict the emergence of depressive impairments in an animal model of chronic epilepsy

  2017cites this paper
• UvA-DARE ( Digital Academic Repository ) Affect modulation of methylphenidate in patients with Attention Deficit Hyperactivity Disorder

  2017cites this paper
• Neurohumoral markers that predict the efficiency of pharmacologic therapy of depressive disorders

  2017cites this paper
• réponse, non-réponse et résistance aux traitements antidépresseurs monoaminergiques. Etude des marqueurs neurogéniques et moléculaires dans un modèle animal d'anxiété-dépression

  2017cites this paper
• Fatty acids in context : Neurometabolic perspectives on depression vulnerability

  2017cites this paper
• Affect modulation of methylphenidate in patients with Attention Deficit Hyperactivity Disorder

  2017cites this paper
• Towards a neurobiological view of depression

  2017cites this paper
• Biological profiling of prospective antidepressant response in major depressive disorder: Associations with (neuro)inflammation, fatty acid metabolism, and amygdala-reactivity.

  2017cites this paper
• Translational Identification of Transcriptional Signatures of Major Depression and Antidepressant Response

  2017cites this paper
• Altered neuronal spontaneous activity correlates with glutamate concentration in medial prefrontal cortex of major depressed females: An fMRI-MRS study.

  2016cites this paper
• Biomarkers for Major Depressive Disorder: Economic Considerations

  2016cites this paper
• Frequency-specific alterations in functional connectivity in treatment-resistant and -sensitive major depressive disorder.

  2016cites this paper
• Treatment of depression with low-strength transcranial pulsed electromagnetic fields: A mechanistic point of view.

  2016cites this paper
• Functional Neuroimaging of State, Course, and Symptom Specificity in Affective Psychopathology

  2015cites this paper
• Functional Neuroimaging of State, Course, and Symptom Specificity in Affective Psychopathology

  2015cites this paper